Looks like they changed the primary outcome measure from a week 13 + 15 average baseline change to just a week 13 baseline change. Got any ideas for why they might have done this? The last trial showed the most dramatic improvement in patients between week 13 and 15 after all.
Market Data 
Markets
AI
